Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

BACKGROUND: At the time of diagnosis, more than 50% of patients with myelodysplastic syndrome have a normal karyotype and are classified as having a favorable prognosis. However, these patients often show very variable clinical outcomes. Furthermore, current diagnostic tools lack the ability to look...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Fernando Barroso, Gonçalves, Romelia Pinheiro, Barbosa, Maritza Cavalcante, Rocha Filho, Francisco Dário, de Jesus dos Santos, Talyta Ellen, dos Santos, Thayna Nogueira, de Vasconcelos, Paulo Roberto Leitão
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109734/
https://www.ncbi.nlm.nih.gov/pubmed/25031059
http://dx.doi.org/10.1016/j.bjhh.2014.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109734/
https://www.ncbi.nlm.nih.gov/pubmed/25031059
http://dx.doi.org/10.1016/j.bjhh.2014.03.007

Ejemplares similares